Brief: Northstrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation In Glp-1
18/06/2026 14:03
BRIEF-Northstrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation In Glp-1 June 18 (Reuters) - PMGC Holdings Inc ELAB.O:
NORTHSTRIVE BIOSCIENCES FILES TWO NEW U.S. PATENT APPLICATIONS TARGETING MUSCLE PRESERVATION IN GLP-1 AND NEXT-GENERATION OBESITY TREATMENT MARKETS
Source text: ID:nGNX8Mb5wk
Further company coverage: ELAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PMGC Holdings
See all newsBrief: PMGC Announces DBA As NorthStrive Holdings Trademark License Agreement, & Website Update
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
Pmgc Holdings Rises As Unit Expands Rights To Ai: discovered obesity, heart disease drug program